Full Papers
using the commercially available DAS6 software (HORIBA JobinY-
von IBH).
HD-OBETA-Et4 (11)
Ethyl 2-[2-(2-aminoethoxy)ethylamino]hexadecanoate (500 mg,
1.2 mmol) was dissolved in acetonitrile (10 mL). Ethyl 2-chloroace-
tate (510 mL, 4.8 mmol, 4 equiv) and DIPEA (1.05 mL, 6 mmol,
5 equiv) were added sequentially and the resulting reaction mix-
ture was stirred overnight at room temperature. Additional ethyl 2-
chloroacetate (130 mL, 1.2 mmol, 1 equiv) and DIPEA (200 mL,
1.2 mmol, 1 equiv) were added and the reaction mixture was
heated to reflux for 2 h. The solvent was removed by evaporation
under reduced pressure. The residue was dissolved in diethyl ether
and was then washed three times with a Na2CO3 saturated solution
and twice with a NaCl saturated solution. The organic phase was
dried over anhydrous Na2SO4, filtered, and the solvent was re-
moved by evaporation under reduced pressure. The residue was
separated by gravimetric chromatography on a silica-gel column
(petroleum ether/ethyl acetate 9:1 as eluent) giving HD-OBETA-Et4
as a colourless oil (720 mg, 1.07 mmol, 89%). 1H NMR (CDCl3,
300 MHz, 298 K): d=4.15 (q, J=7.1 Hz, 4H), 4.14 (q, J=7.0 Hz, 2H),
4.13 (q, J=7.0 Hz, 2H), 3.59–3.42 (m, 10H), 3.38 (t, J=7.4 Hz, 1H),
2.97–2.83 (m, 2H), 2.92 (t, J=5.6 Hz, 2H), 1.75–1.51 (m, 2H), 1.48–
1.09 (m, 40H), 0.88 ppm (t, J=6.7 Hz, 3H); 13C NMR (CDCl3,
75.4 MHz, 298 K): d=173.6 (C), 172.2 (2C), 171.4 (C), 70.7 (2CH2),
70.3 (CH2), 65.4 (CH), 60.4 (2CH2), 60.3 (CH2), 60.2 (CH2), 56.0 (CH2),
53.8 (CH2), 53.2 (CH2), 52.2 (CH2), 32.0 (CH2), 30.6 (CH2), 29.7 (9CH2),
29.6 (CH2), 29.5 (CH2), 26.2 (CH2), 22.7 (CH2), 14.4 (CH3), 14.3 (2CH3),
14.1 ppm (CH3).
2-Bromostearoyl chloride
Stearic acid (40 g, 140.6 mmol) was dissolved in SOCl2 (50 mL,
0.7 mol, 5 equiv) and the homogeneous solution was heated to
reflux for one hour. Bromine (44.5 g, 2 equiv, 278 mmol) was added
dropwise while heating at reflux and the resulting reaction mixture
was stirred at reflux for 3 h and overnight at room temperature.
Volatile compounds were removed under reduced pressure to
yield 2-bromostearoyl chloride as a light yellowish viscous oil
(53.4 g, 139.8 mmol, 99%). 1H NMR (CDCl3, 300 MHz, 298 K): d=
4.49 (t, J=6.6 Hz, 1H), 2.23–1.95 (m, 2H), 1.58–1.20 (m, 28H),
0.87 ppm (t, J=6.7 Hz, 3H); 13C NMR (CDCl3, 75.4 MHz, 298 K): d=
170.2 (C), 54.2 (CH), 34.9 (CH2), 32.0 (CH2), 29.8 (6CH2), 29.65 (CH2),
29.51 (CH2), 29.46 (CH2), 29.30 (CH2), 28.8 (CH2), 26.9 (CH2), 22.8
(CH2), 14.2 ppm (CH3).
Ethyl 2-bromostearoate (9)
2-Bromostearoyl chloride (10 g, 26.2 mmol) was dissolved in etha-
nol (100 mL) and the resulting reaction mixture was heated to
reflux for one hour, monitoring periodically by using thin-layer cho-
romatography (TLC) (petroleum ether/ethyl acetate 95:5). An
excess amount of ethanol was removed by evaporation under re-
duced pressure to give ethyl 2-bromostearate as a white solid
(10.3 g, 26.4 mmol, 96%). 1H NMR (CDCl3, 300 MHz, 298 K): d=
4.24–4.12 (m, 3H), 2.10–1.85 (m, 2H), 1.35–1.12 (m, 31H), 0.85 ppm
(t, J=6.1 Hz, 3H); 13C NMR (CDCl3, 75.4 MHz, 298 K): d=174.5 (C),
61.9 (CH2), 46.2 (CH), 35.0 (CH2), 32.0 (CH2), 29.73 (7CH2), 29.65
(CH2), 29.54 (CH2), 29.43 (CH2), 29.39 (CH2), 28.9 (CH2), 27.3 (CH2),
22.8 (CH2), 14.1 (CH3), 14.0 ppm (CH3).
HD-OBETA·2HCl (12)
HD-OBETA-Et4 (700 mg, 1.04 mmol) was dissolved in ethanol (5 mL)
and solid NaOH (210 mg, 5.2 mmol, 5 equiv) was added at room
temperature. The resulting reaction mixture was stirred at room
temperature overnight. The hydrolysis was checked by 1H NMR
spectroscopy. Na4(HD-OBETA): 1H NMR (CD3OD, 300 MHz, 298 K):
d=3.50 (t, J=4.6 Hz, 4H), 3.14 (d, J=16.6 Hz, 1H), 3.01 (d, J=
16.5 Hz, 1H), 3.07–2.93 (m, 5H), 2.70–2.62 (m, 2H), 2.59–2.51 (m,
2H), 1.69–1.43 (m, 2H), 1.40–1.20 (m, 28H), 0.89 ppm (t, J=6.7 Hz,
3H). The resulting solution was acidified to pH 2 with concentrated
hydrochloric acid. The white precipitate was centrifuged, washed
with cold water, and the residual solvent was removed under re-
Ethyl 2-[2-(2-aminoethoxy)ethylamino]hexadecanoate (10)
Ethyl 2-bromostearate (4.5 g, 11.5 mmol, 3 equiv) was dissolved in
acetonitrile (75 mL) and 2,2’-oxybisethylamine (400 mg, 3.8 mmol,
1 equiv) was added in one portion. Powdered potassium carbonate
(8.0 g, 57.5 mmol, 5 equiv) was added and the resulting reaction
mixture was vigorously stirred and heated to reflux for 6 h, moni-
toring periodically by TLC. Potassium iodide (190 mg, 1.15 mmol,
0.1 equiv) was added and the reaction mixture was stirred for 2 h
at reflux and overnight at room temperature. The solvent was re-
moved by evaporation under reduced pressure. The residue was
dissolved with dichloromethane and washed three times with
a Na2CO3 saturated solution and twice with a NaCl saturated solu-
tion. The organic phase was dried over anhydrous Na2SO4, filtered,
and the solvent was removed under reduced pressure. The residual
oil was separated by gravimetric chromatography on a silica-gel
column (eluent: petroleum ether/ethyl acetate, 9:1!6:4 gradient),
yielding ethyl 2-[2-(2-aminoethoxy)ethylamino]hexadecanoate as
duced pressure leading to HD-OBETA·2HCl as
a white solid
1
(650 mg, 1.03 mmol). H NMR (CD3OD, 300 MHz, 323 K): d=3.91 (s,
4H), 3.77–3.63 (m, 7H), 3.37 (t, J=4.9 Hz, 2H), 3.20 (t, J=5.1 Hz,
2H), 1.93–1.68 (m, 2H), 1.55–1.18 (m, 28H), 0.89 ppm (t, J=6.7 Hz,
3H); 13C NMR (CD3OD, 75.4 MHz, 323 K): d=170.0 (4C), 67.6 (CH2),
66.8 (CH), 66.5 (CH2), 56.1 (2CH2), 55.1 (CH2), 53.7 (CH2), 53.5 (CH2),
48.0 (CH2), 31.7 (CH2), 29.4 (11CH2), 29.1 (CH2), 28.6 (CH2), 26.3
(CH2), 22.3 (CH2), 11.6 ppm (CH3).
Gd(HD-OBETA)
Gd(HD-OBETA) was synthesised by adding small volumes of a stock
solution of GdCl3·6H2O to a solution of the ligand, while maintain-
ing the pH at 6.5 with diluted NaOH. The complexation process
was monitored by measuring the change in the longitudinal water
proton relaxation rate (R1) at 20 MHz and 258C (pH 6.5) as a func-
tion of the concentration of GdIII.
1
a colourless oil (740 mg, 1.8 mmol, 47%). H NMR (CDCl3, 300 MHz,
298 K): d=4.21–4.09 (m, 2H), 3.58–3.38 (m, 4H), 3.20 (t, J=6.6 Hz,
1H), 2.83 (t, J=5.2 Hz, 2H), 2.82–2.74 (m, 1H), 2.60 (dt, J=11.9, J=
5.0 Hz, 1H), 1.81 (brs, 3H), 1.64–1.54 (m, 2H), 1.33–1.18 (m, 31H),
0.84 ppm (t, J=6.7 Hz, 3H); 13C NMR (CDCl3, 75.4 MHz, 298 K): d=
175.5 (C), 73.1 (CH2), 70.6 (CH2), 61.7 (CH), 60.5 (CH2), 47.6 (CH2),
41.9 (CH2), 33.6 (CH2), 32.0 (CH2), 29.74 (8CH2), 29.62 (CH2), 29.51
(CH2), 29.42 (CH2), 28.8 (CH2), 22.7 (CH2), 14.4 (CH3), 14.2 ppm (CH3);
ESI+MS: m/z: 415.25 [M+H]+.
Liposome preparation
Long-circulating liposomes were prepared as described previous-
ly.[18] The total amount of phospholipids and the amphiphilic com-
ChemPlusChem 2016, 81, 235 – 241
240
ꢀ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim